Throughout the month of 10/20/20 - 11/19/20, the price experienced a -6% Downtrend. During the week of 11/12/20 - 11/19/20, the stock fell -4%. Bearish Trend. Stock Information Charts and data; Shareholder Services An evolution of the previous Purpose Blueprint, implemented in , the Purpose Blueprint. Press Releases (Most Recent). , BLUEPRINT MEDICINES CORPORATION STOCK INCENTIVE PLAN). , Blueprint Medicines Reports Strong First. Blueprint Medicines DB:2L9 Stock Report ; 52 Week Low, US$ ; Beta, ; 11 Month Change, % ; 3 Month Change, % ; 1 Year Change, %. Blueprint Medicines market cap as of August 30, is $B. Compare BPMC With Other Stocks.
stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. Blueprint Medicines Corp Stock Buy Hold or Sell Recommendation · Stocks. USA. Given the investment horizon of 90 days and your above-average risk tolerance. Blueprint's stock falls 11% after sharing new Phase 2 data for its rare-disease therapy. Shares of Blueprint Medicines Corp. tumbled % in premarket trading. Details · Stock Symbol NASDAQ:BPMC · Company Type For Profit. Stock Quote ; Last Trade: US$ ; Daily Change: ; Daily Volume: , ; Market Cap: US$B ; License Error: Access from crawling bot. Our commitment to patients. At Blueprint Medicines, we work together in pursuit of one common goal: to dramatically improve and extend patients' lives. read on. We have a proven track record of developing medicines, and we aim to scale our impact by advancing innovative therapies for large patient populations. Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/. Find the latest Blueprint Medicines Corporation (BPMC) stock quote, history, news and other vital information to help you with your stock trading and. What is Blueprint Medicines Corp share price today? Blueprint Medicines Corp (BPMC) share price today is $ AYVAKIT, Blueprint Medicines, YourBlueprint and associated logos are trademarks of Blueprint Medicines Corporation. All other trademarks are property of.
Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines in two core focus areas. Find the latest Blueprint Medicines Corporation (BPMC) stock quote, history, news and other vital information to help you with your stock trading and. Blueprint Medicines Corporation's stock symbol is BPMC and currently trades under NASDAQ. It's current price per share is approximately $ What are your. compare icon Compare BPMC vs All Stocks ; ai score. BPMC (Blueprint Medicines) vs IBRX (ImmunityBio). Nasdaq Listed. Market: Pre-Market. Blueprint Medicines Corporation Common Stock (BPMC). Bid: $ X Ask: $ X Volume: , 52 Week Range. CAMBRIDGE, Mass., June 30, /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced strategic financing collaborations with Sixth. See the latest Blueprint Medicines Corp stock price (BPMC:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Blueprint Medicines market value as of August 30, is $B. Compare BPMC With Other Stocks. Blueprint Medicines Corp (BPMC) ; Exchange, NASDAQ, NASDAQ ; Open, , ; High, , ; Low, , ; Last, ,
Throughout the month of 10/20/20 - 11/19/20, the price experienced a -6% Downtrend. During the week of 11/12/20 - 11/19/20, the stock fell -4%. Bearish Trend. Discover historical prices for BPMC stock on Yahoo Finance. View daily, weekly or monthly format back to when Blueprint Medicines Corporation stock was issued. Blueprint Medicines Corporation - news published - readings · Statement of Changes in Beneficial Ownership - Form 4 · Quarterly Report for Quarter. Dividend capture strategy is based on BPMC's historical data. Past performance is no guarantee of future results. Step 1: Buy BPMC shares 1 day before the ex-. Blueprint Medicines Corp. analyst ratings, historical stock prices, earnings estimates & actuals. BPMC updated stock price target summary.
See the latest Blueprint Medicines Corp stock price (BPMC:XNAS), related news, valuation, dividends and more to help you make your investing decisions. According to Blueprint Medicines 's latest financial reports and stock price the company's current number of shares outstanding is 61,, At the end of. Stock price for similar companies or competitors ; Blueprint Medicines Logo · Pacific Biosciences. PACB. $, %, USA ; Blueprint Medicines Logo. US Stock MarketDetailed Quotes. BPMC Blueprint Medicines. Close Aug 9 ET. + +%. Market CapB. P/E (TTM) High. Low. Blueprint Medicines Corp (BPMC) ; Exchange, NASDAQ, NASDAQ ; Open, , ; High, , ; Low, , ; Last, , The mean historical Enterprise Value of Blueprint Medicines Corporation over the last ten years is B. The current B Enterprise Value has changed %. What is Blueprint Medicines Corp share price today? Blueprint Medicines Corp (BPMC) share price today is $ This is an initial public offering of shares of common stock of Blueprint Medicines Corporation. All of the shares of common stock are being sold by the company. Blueprint Medicines Corp. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Blueprint Medicines is registered under the ticker NASDAQ:BPMC. Their stock opened with $ in its Apr 27, IPO. Stock Symbol NASDAQ:BPMC. Details · Stock Symbol NASDAQ:BPMC · Company Type For Profit. Discover historical prices for BPMC stock on Yahoo Finance. View daily, weekly or monthly format back to when Blueprint Medicines Corporation stock was issued. The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms. Press Releases (Most Recent). , BLUEPRINT MEDICINES CORPORATION STOCK INCENTIVE PLAN). , Blueprint Medicines Reports Strong First. Blueprint Medicines Corporation - news published - readings · Statement of Changes in Beneficial Ownership - Form 4 · Quarterly Report for Quarter. Interactive chart of historical stock value for Blueprint Medicines over the last 10 years. The value of a company is typically represented by its market. Dividend capture strategy is based on BPMC's historical data. Past performance is no guarantee of future results. Step 1: Buy BPMC shares 1 day before the ex-. As of September Blueprint Medicines has a market cap of $ Billion. This makes Blueprint Medicines the world's th most valuable company. AYVAKIT, Blueprint Medicines, YourBlueprint and associated logos are trademarks of Blueprint Medicines Corporation. All other trademarks are property of. BPMC. Blueprint Medicines. $B ; ALNY. Alnylam Pharma. $B ; CRSP. Crispr Therapeutics AG. $B ; KURA. Kura Oncology. $B ; FGEN. FibroGen. $M. Blueprint Medicines Corp Stock Buy Hold or Sell Recommendation · Stocks. USA. Given the investment horizon of 90 days and your above-average risk tolerance. Blueprint Medicines market cap as of August 30, is $B. Compare BPMC With Other Stocks. Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. Blueprint Medicines Corporation's stock symbol is BPMC and currently trades under NASDAQ. It's current price per share is approximately $ What are your. Blueprint Medicines Corp. analyst ratings, historical stock prices, earnings estimates & actuals. BPMC updated stock price target summary. Throughout the month of 10/20/20 - 11/19/20, the price experienced a -6% Downtrend. During the week of 11/12/20 - 11/19/20, the stock fell -4%. Bearish Trend. We have a proven track record of developing medicines, and we aim to scale our impact by advancing innovative therapies for large patient populations. 54 minutes ago. Blueprint's stock falls 11% after sharing new Phase 2 data for its rare-disease therapy. Shares of Blueprint Medicines Corp. tumbled % in premarket trading.